Latest Breaking News On - Hans eriksson - Page 2 : comparemela.com

Head-to-head Trial of Prolonged-Release Oral Ketamine Formulation, KET01, and Intranasal SPRAVATO®, Finds Less Incidence of Dissociation or Cardiovascular Effects with Oral Treatment, at doses used for Treatment-Resistant Depression

Head-to-head Trial of Prolonged-Release Oral Ketamine Formulation, KET01, and Intranasal SPRAVATO®, Finds Less Incidence of Dissociation or Cardiovascular Effects with Oral Treatment, at doses used for Treatment-Resistant Depression
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Baden wübergCzech republicUnited statesSouth africaSwitzerland generalHans erikssonMckenna millerSophia bashfordDevelco pharmaKetabon gmbhHome administrationBrain healthKetabon programHolding gmbProlonged release oral ketamine formulationFinds less incidence

7 healthy lifestyle changes that could help reduce risk of depression, says study: Enormous benefits

There are some healthy things people can do to reduce their risk of depression, as revealed in a new study published in the journal Nature Mental Health. Here are the seven steps.

United kingdomNew jerseyUnited statesMelissa rudyJonathan carrollDaniel gehrlachChris tuellBarbara sahakianMelanie avalonHans erikssonUniversity of cambridgeDepartment of psychiatryBrain healthNutrition examination surveyJersey shore medical centerNational health

Study Indicates Take-at-Home, Oral Ketamine is an Effective Option for Treatment-Resistant Depression

The daily oral formulation of ketamine, KET01, has the potential to greatly improve the standard treatment practices for treatment-resistant depression, according to investigators.

Czech republicDevelco pharmaHans erikssonMartin walterPsychotherapy of university jenaDepartment of psychiatryBrain healthUniversity jenaClinician administered dissociative states scaleTop line results from phaseOral ketamine optionKetamine demonstratedBlind trial shows low cost subcutaneous versionEffective over placeboTreating treatment resistant

Ketabon GmbH Reports Top-Line Results from Phase 2 Trial of Take-at-Home, Oral Ketamine Option for Treatment-Resistant Depression

Ketabon GmbH Reports Top-Line Results from Phase 2 Trial of Take-at-Home, Oral Ketamine Option for Treatment-Resistant Depression
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Czech republicSwitzerland generalBaden wübergSouth africaAnne donohoeSophia bashfordHans erikssonMartin walterDevelco pharmaHolding gmbBrain healthKetabon programUniversity jenaHead of the department psychiatryGmbh reports top line resultsOral ketamine option

HMNC Brain Health Begins Phase 2 Study for Personalized

HMNC Brain Health Begins Phase 2 Study for Personalized
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Sophia bashfordHans erikssonAnne donohoeMaximilian doeblerBrain healthHolding gmbMajor depressive disorderChief business officerChief medical officerTreatment resistant depression